We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+40.23%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$577M
AUM Growth
+$88.3M
Cap. Flow
+$214K
Cap. Flow %
0.04%
Top 10 Hldgs %
83.07%
Holding
25
New
–
Increased
8
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$4.34M
2
AXDX
Accelerate Diagnostics
AXDX
+$3.97M
3
PACB icon
Pacific Biosciences
PACB
+$3.77M
4
MZOR
Mazor Robotics Ltd.
MZOR
+$3.38M
5
TSRO
TESARO, Inc.
TSRO
+$2.23M

Top Sells

Rank Stock Value
1
CMRX
Chimerix, Inc.
CMRX
+$9M
2
NXTM
NxStage Medical Inc.
NXTM
+$3.62M
3
RGLS
Regulus Therapeutics
RGLS
+$2.45M
4
AGEN
Agenus
AGEN
+$1.79M
5
OPK icon
Opko Health
OPK
+$864K

Sector Composition

Rank Sector Weight
1 Healthcare 89.69%
2 Consumer Staples 0.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$121M 21.01%
564,354
+21,765
+4% +$3.97M
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
$72.1M 12.49%
3,291,001
-194,077
-6% -$3.62M
QDEL icon
3
QuidelOrtho
QDEL
$1.14B
$59.3M 10.27%
2,796,284
-20,000
-0.7% -$406K
PACB icon
4
Pacific Biosciences
PACB
$432M
$48M 8.32%
3,656,431
+420,270
+13% +$3.77M
OPK icon
5
Opko Health
OPK
$1.25B
$39.3M 6.82%
3,913,800
-86,200
-2% -$864K
ACOR
6
DELISTED
Acorda Therapeutics
ACOR
$34.9M 6.05%
6,799
– –
MZOR
7
DELISTED
Mazor Robotics Ltd.
MZOR
$28.6M 4.96%
2,816,635
+323,724
+13% +$3.38M
TSRO
8
DELISTED
TESARO, Inc.
TSRO
$28.3M 4.9%
540,966
+46,716
+9% +$2.23M
PGEN icon
9
Precigen
PGEN
$1.97B
$28.1M 4.87%
940,978
+128,857
+16% +$4.34M
ARAY icon
10
Accuray
ARAY
$29M
$19.5M 3.37%
2,884,305
– –
VRML
11
DELISTED
Vermillion, Inc.
VRML
$15.5M 2.69%
8,624,225
– –
AGEN
12
Agenus
AGEN
$275M
$13M 2.25%
146,005
-19,614
-12% -$1.79M
AMRN
13
Amarin Corp
AMRN
$293M
$12.6M 2.18%
332,290
+28,446
+9% +$1.12M
WBMD
14
DELISTED
WebMD Health Corp.
WBMD
$11.5M 1.99%
238,103
– –
HNSN
15
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$10.5M 1.81%
4,491,820
+4
+0% +$13
BIOL
16
DELISTED
Biolase, Inc.
BIOL
$8.86M 1.53%
842
+4
+0.5% +$43.7K
TTHI
17
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$7.5M 1.3%
3,908,461
-57,561
-1% -$109K
CMRX
18
DELISTED
Chimerix, Inc.
CMRX
$6.59M 1.14%
736,421
-250,000
-25% -$9M
CFRX
19
DELISTED
ContraFect Corporation
CFRX
$5.62M 0.97%
1,478
– –
BIIB icon
20
Biogen
BIIB
$30.4B
$2.37M 0.41%
7,723
– –
YTEN
21
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$1.44M 0.25%
97
-3
-3% -$60.5K
VANI icon
22
Vivani Medical
VANI
$113M
$1.2M 0.21%
8,477
– –
TCRT icon
23
Alaunos Therapeutics
TCRT
$4.64M
$1.09M 0.19%
877
-18
-2% -$29.8K
RGLS
24
DELISTED
Regulus Therapeutics
RGLS
– –
-3,121
Closed -$2.45M
THOR
25
DELISTED
THORATEC CORPORATION
THOR
– –
-5,000
Closed -$316K

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Oracle Investment Management held 25 positions worth $577M, up 18% from $489M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Oracle Investment Management's Q4 2015 filing shows 8 increased, 8 reduced and 2 closed positions. The largest sale was Chimerix, Inc., an estimated $9M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 87% a quarter earlier, followed by Consumer Staples.

  • Oracle Investment Management added most to Precigen in Q4 2015, an estimated $4.34M increase.
  • Oracle Investment Management's biggest Q4 2015 reduction was Chimerix, Inc., cutting an estimated $9M.
  • Oracle Investment Management fully exited Regulus Therapeutics in Q4 2015, selling an estimated $2.45M.
  • Oracle Investment Management's ten largest holdings make up 83% of its $577M portfolio in Q4 2015.
  • Oracle Investment Management opened 0 new positions and closed 2 in Q4 2015.
  • Oracle Investment Management's portfolio value rose 18% quarter-over-quarter to $577M.

Based on Oracle Investment Management's 13F filing for Q4 2015, filed 9 Feb 2016.